SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
SGNT was delisted on the 29th of August, 2016.
0 hedge funds and large institutions have $0 invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 128 closing their positions.
100% less funds holding
Funds holding: 128 → 0 (-128)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $486M → $0 (-$486M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 128
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$97.3M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$36.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$29M |
| 4 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$27.7M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$24.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
126
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$2K | -106 | Closed |
|
|
MFS
127
MSI Financial Services
Springfield,
Massachusetts
| – | -$2K | -101 | Closed |
|
SGNT Hedge Fund Activity: Q3 2016 in Review
0 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q3 2016, worth a combined $0 — down 100% from $486M a quarter earlier.
Sellers outnumbered buyers: 128 funds closed out of SGNT and 0 opened new positions — a net loss of 128 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vivo Capital, exiting entirely with an estimated $97.3M sold.
- 0 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q3 2016, down from 128 in Q2 2016.
- Funds reported $0 of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q3 2016, down 100% quarter-over-quarter.
- 0 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q3 2016 and 128 closed out, a net change of -128 holders.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q3 2016 was Vivo Capital, an estimated $97.3M sold.
Based on aggregated 13F filings for Q3 2016.